Predictive oncology stock.

Track Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Predictive oncology stock. Things To Know About Predictive oncology stock.

Predictive Oncology Inc (POAI) stock is trading at $0.29 as of 2:08 PM on Friday, Mar 31, a gain of $0.01, or 3.39% from the previous closing price of $0.28. The stock has traded between $0.28 and $0.30 so far today. Volume today is below average. So far 218,615 shares have traded compared to average volume of 340,765 shares.Predictive Oncology CEO Raymond Vennare and Cvergenx CEO Javier Torres-Roca join Natalie Stoberman to share news of their new partnership to develop the first-ever genomics-based approach to precis...EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and ...Aug 16, 2023 · Predictive Oncolog y : Offers a compelling use case for AI in the area of cancer research. Remark ( MARK ): One of the smallest of small-cap stocks may have one of the biggest upsides of any AI stock.

Apr 20, 2023 · Predictive Oncology’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol POAI and will begin trading on a split-adjusted basis when the market opens on Monday ... May 26, 2023 · Predictive Oncology (NASDAQ: POAI) is an early-stage AI pharma stock with a differentiated business model. The company owns a biorepository of tumor samples, a lab and a good manufacturing ...

Stock analysis for Predictive Oncology Inc (POAI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Nov 18, 2023 · Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.98 and traded as low as $3.11. Predictive Oncology shares last traded at $3.11, with a volume of 20,587 shares. Predictive Oncology Price Performance The stock […] Predictive Oncology Inc (POAI) stock is trading at $5.48 as of 10:17 AM on Thursday, Jun 29, a rise of $0.35, or 6.82% from the previous closing price of $5.13. The stock has traded between $5.36 and $5.79 so far today. Volume today is 132,703 compared to average volume of 171,018. More About Predictive Oncology IncBenzinga — Why Predictive Oncology Stock Is Getting Hammered News • Apr 13, 2023 Digiday — ‘All options are on the table’: Why Version1 is seeking a merger with another esports companyComplete Predictive Oncology Inc. stock information by Barron's. View real-time POAI stock price and news, along with industry-best analysis.

Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System ...

२०१९ जुलाई १८ ... Predictive Oncology (Nasdaq: POAI) subsidiary Helomics, an artificial ... stock may decline as a result of the merger; (ii) risks related to ...Find real-time POAI - Predictive Oncology Inc stock quotes, company profile, news and forecasts from CNN Business. 0.73%. $39.94B. Astellas Pharma Inc. -4.37%. ¥3.42T. PYXS | Complete Pyxis Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The estimated Net Worth of Robert L Myers is at least $560 Thousand dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $232,324 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System ...Real-time quotes, advanced visualizations, historical statements, and much more. Selling, General and Administrative Excl. Other. POAI - Predictive Oncology Inc - Stock screener for investors and traders, financial visualizations.

Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022This article will tell you the best AI stocks under $1 to buy right now! ... Predictive Oncology is a Minnesota-based data and AI-driven discovery services company providing predictive models of tumor drug response. One of the subsidiaries of Predictive Oncology, TumorGenesis, utilizes specific and highly differentiated methods to grow …FOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced that Thomas Bock, M.D., CEO of Notable Labs, will participate in a fireside chat at the JMP …Nov 13, 2023 · POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35... The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of …Predictive Oncology. POAI. $3.09 ... as of November 29 4:00:00 PM EST. Predictive Oncology (POAI) Stock Price Performance. Predictive Oncology (POAI) Stock Key Data. Summary Additional Data ...Forecst.com predicts future values using technical analysis of a large number of analytical parameters. POAI stock returns are also predicted based on historical data. According to our research, POAI stock is a bad long-term investment. POAI share price has been in a bear cycle for the past year. Predictive Oncology Inc. stock trend is …

About the Oncology Pharma, Inc. stock forecast. As of 2023 December 03, Sunday current price of ONPH stock is 0.001$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Oncology Pharma stock price has been showing a declining tendency so we believe that similar market segments were not …Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …

Stock analysis for Predictive Oncology Inc (POAI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Predictive Oncology share forecasts, stock quote and buy / sell signals below. According to present data Predictive Oncology's POAI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). By Chris Markoch, InvestorPlace Contributor Aug 16, 2023, 5:11 pm EST. Finding little-known AI stocks may be critical to unearthing the true opportunity in AI. Predictive Oncology ( POAI ): Offers ...The all-time high Predictive Oncology stock closing price was 27200.00 on November 09, 2015. The Predictive Oncology 52-week high stock price is 13.88, which is 385.3% above the current share price. The Predictive Oncology 52-week low stock price is 2.47, which is 13.6% below the current share price. The average Predictive Oncology stock price ...Clovis Oncology (NASDAQ:CLVS) issued its quarterly earnings data on Wednesday, November, 3rd. The biopharmaceutical company reported ($0.56) earnings per share for the quarter, missing analysts' consensus estimates of ($0.48) by $0.08. The biopharmaceutical company had revenue of $37.92 million for the quarter, compared to …Complete Predictive Oncology Inc. stock information by Barron's. View real-time POAI stock price and news, along with industry-best analysis.

The estimated Net Worth of Carl I. Schwartz is at least $869 Thousand dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over $435,062 and over the last 7 years he sold POAI stock worth over $544. In addition, he makes $433,000 as CEO & Director at Predictive Oncology.

The shares of common stock described above (but not the warrants or the shares of common stock underlying the warrants) were offered by the Company in the registered direct offerings pursuant to ...

Jun 27, 2023 · Here are three artificial intelligence stocks that could be acquired. SoundHound ( AI ): The company is exposed to a $500 million a year opportunity with autos and restaurants. Predictive Oncology ... Minitab Statistical Software is a powerful tool that enables businesses to analyze data, identify trends, and make informed decisions. With its advanced capabilities, Minitab can also be used for predictive modeling.2.47 Today ||| 52-Week Range 13.88 -47.49% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs. Health Technology News Chart Latest POAI News | Press Releases No...Here are three top AI stocks trading under $10 a share. Lantern Pharma Inc. ( LTRN ): A small, potential game-changer in the fight against cancer. Predictive Oncology (POAI): While risky, POAI ...Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ...POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35...The estimated Net Worth of Robert L Myers is at least $560 Thousand dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $232,324 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.Latest company newsPredictive Oncology forms a strategic partnership that has the potential to revolutionize the field of radiation oncology. Digital newsroomLinks to …Hernandez-Boussard, T., Macklin, P., Greenspan, E.J. et al. Digital twins for predictive oncology will be a paradigm shift for precision cancer care. Nat Med 27, 2065–2066 (2021 ...Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …

२०२० जुन ३० ... ... Predictive Oncology Inc: * PREDICTIVE ONCOLOGY FILES PROSPECTUS RELATES TO OFFER, RESALE OF UP TO 1.7 MILLION SHARES OF COMMON STOCK BY ...Nov 27, 2023 · A high-level overview of Predictive Oncology Inc. (POAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Predictive Oncology up 13% premarket on coronavirus mention. SA NewsMon, Mar. 02, 2020. Get the latest news and real-time alerts from Predictive Oncology Inc. (POAI) stock at Seeking Alpha.Instagram:https://instagram. forex.com paper tradingbest virtual reality stocksxtb trading platformclearwater analytics stock Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Predictive Oncology Inc. Common Stock (POAI) Stock Price, Quote, News & History | Nasdaq MY QUOTES: POAI Edit my quotes Predictive Oncology Inc. Common Stock (POAI) 0 Add to... cdw incdividend return calculator Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …On average, Predictive Oncology executives and independent directors trade stock every 71 days with the average trade being worth of $99,350. The most recent stock trade was executed by Robert L Myers on 25 September 2023, trading 1,667 units of POAI stock currently worth $5,334. mmm lawsuit Find the latest Ikena Oncology, Inc. (IKNA) stock quote, history, news and other vital information to help you with your stock trading and investing.EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and ...